{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:09:03Z","timestamp":1790611743402,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010354","name":"Hellenic Society of Gastroenterology","doi-asserted-by":"crossref","award":["4704\/2011"],"award-info":[{"award-number":["4704\/2011"]}],"id":[{"id":"10.13039\/501100010354","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ejim.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T16:58:10Z","timestamp":1462035490000},"page":"84-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area"],"prefix":"10.1016","volume":"32","author":[{"given":"Sotirios D.","family":"Georgopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Xirouchakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Martinez-Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Zampeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Grivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-4950","authenticated-orcid":false,"given":"Charikleia","family":"Spiliadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sotiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Petraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostantinos","family":"Zografos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Laoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0975-2607","authenticated-orcid":false,"given":"Dionysios","family":"Sgouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kasapidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Michopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2016.04.011_bb0005","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Clinical practice. Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2016.04.011_bb0010","doi-asserted-by":"crossref","first-page":"757926","DOI":"10.1155\/2012\/757926","article-title":"Helicobacter pylori eradication therapies in the era of increasing antibiotic resistance: a paradigm shift to improved efficacy","volume":"2012","author":"Georgopoulos","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejim.2016.04.011_bb0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A report card to grade Helicobacter pylori therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2016.04.011_bb0020","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: a systematic review","volume":"19","author":"De Francesco","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.ejim.2016.04.011_bb0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/apt.13497","article-title":"Review article: the global emergence of Helicobacter pylori antibiotic resistance","volume":"43","author":"Thung","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2016.04.011_bb0030","first-page":"646","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"61","author":"Graham","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2016.04.011_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/MCG.0b013e31826015b0","article-title":"Nonbismuth quadruple \u201cconcomitant\u201d therapy versus standard triple therapy, both of the duration of 10days, for first-line H. pylori eradication: a randomized trial","volume":"47","author":"Georgopoulos","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14656566.2013.763926","article-title":"Current options for the treatment of Helicobacter pylori","volume":"14","author":"Georgopoulos","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2016.04.011_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection-the Maastricht IV\/Florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2016.04.011_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1523-5378.2011.00911.x","article-title":"Evaluation of a four-drug, three-antibiotic, non bismuth-containing \u201cconcomitant\u201d therapy as first-line Helicobacter pylori eradication regimen in Greece","volume":"17","author":"Georgopoulos","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2016.04.011_bb0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/hel.12062","article-title":"Clinical evaluation of a ten-day regimen with esomeprazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area","volume":"18","author":"Georgopoulos","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2016.04.011_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2009.09.030","article-title":"Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1751-2980.2012.00575.x","article-title":"Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication","volume":"13","author":"Huang","year":"2012","journal-title":"J Dig Dis"},{"key":"10.1016\/j.ejim.2016.04.011_bb0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/gutjnl-2013-304820","article-title":"Randomized clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice","volume":"63","author":"McNicholl","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2016.04.011_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","article-title":"14-day triple, 5-day concomitant and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomized trial","volume":"378","author":"Greenberg","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2016.04.011_bb0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clinre.2013.04.003","article-title":"Concomitant, sequential and hybrid therapy for H. pylori eradication: a pilot study","volume":"37","author":"Zullo","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0085","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1099\/jmm.0.072322-0","article-title":"Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study","volume":"63","author":"De Francesco","year":"2014","journal-title":"J Med Microbiol"},{"issue":"10","key":"10.1016\/j.ejim.2016.04.011_bb0090","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1128\/AAC.02922-14","article-title":"Randomized controlled trial comparing 7-day triple, 10-day sequential and 7-day concomitant therapies for Helicobacter pylori infection","volume":"58","author":"Hsu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejim.2016.04.011_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomized trial","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2016.04.011_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ajg.2014.26","article-title":"A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial","volume":"109","author":"Zhou","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0105","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/j.gastro.2013.07.054","article-title":"Is there a non-bismuth quadruple therapy that can reliably overcome bacterial resistance?","volume":"145","author":"Georgopoulos","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2016.04.011_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/CEG.S25419","article-title":"Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori","volume":"5","author":"Gisbert","year":"2012","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1523-5378.2012.00953.x","article-title":"Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand","volume":"17","author":"Kongchayanun","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2016.04.011_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1523-5378.2011.00829.x","article-title":"Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14days?","volume":"16","author":"Hsu","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2016.04.011_bb0125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1523-5378.2011.00890.x","article-title":"Key points for designing and reporting Helicobacter pylori therapeutic trials: a personal view","volume":"16","author":"Calvet","year":"2011","journal-title":"Helicobacter"},{"issue":"Suppl. 2","key":"10.1016\/j.ejim.2016.04.011_bb0130","first-page":"S10","volume":"41","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2016.04.011_bb0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1469-0691.2002.00435.x","article-title":"The status of antimicrobial resistance of Helicobacter pylori in Eastern Europe","volume":"8","author":"Boyanova","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejim.2016.04.011_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2016.04.011_bb0145","doi-asserted-by":"crossref","first-page":"f4587","DOI":"10.1136\/bmj.f4587","article-title":"Global eradication rates for H pylori infection: systematic review and meta-analysis of sequential therapy","volume":"347","author":"Gatta","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2016.04.011_bb0150","article-title":"Concomitant therapy for H. pylori infection is superior to sequential therapy if they are fairly compared","volume":"347","author":"Molina-Infante","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2016.04.011_bb0155","first-page":"280","article-title":"\u201cConcomitant\u201d or \u201csequential\u201d eradication of H. pylori: which regimen comes first?","volume":"27","author":"Georgopoulos","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0160","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4166\/kjg.2014.64.5.260","article-title":"Ten day concomitant therapy is superior to ten day sequential therapy for helicobacter pylori eradication","volume":"64","author":"Kim","year":"2014","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3748\/wjg.v21.i1.351","article-title":"Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies","volume":"21","author":"Lee","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2016.04.011_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365521.2015.1079646","article-title":"Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study","volume":"51","author":"Apostolopoulos","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ejim.2016.04.011_bb0175","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/jgh.12984","article-title":"Sequential or concomitant therapy for eradication of H. pylori infection: a systematic review and meta-analysis","volume":"30","author":"Kim","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0180","doi-asserted-by":"crossref","first-page":"h4052","DOI":"10.1136\/bmj.h4052","article-title":"Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis","volume":"351","author":"Li","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2016.04.011_bb0185","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/jgh.12892","article-title":"Ten-day triple therapy versus sequential therapy versus concomitant therapy as first line treatment for Helicobacter pylori infection","volume":"30","author":"Ang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"Graham","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/hel.12034","article-title":"Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study","volume":"18","author":"Lim","year":"2013","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.ejim.2016.04.011_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MCG.0b013e31820ac05e","article-title":"Sequential therapy: understanding and appreciating sequential therapy for H. pylori eradication","volume":"45","author":"Graham","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/hel.12176","article-title":"Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled study","volume":"20","author":"Tsay","year":"2015","journal-title":"Helicobacter"},{"key":"10.1016\/j.ejim.2016.04.011_bb0210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/apt.13495","article-title":"Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection","volume":"43","author":"Liou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2016.04.011_bb0215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/00365521.2014.896409","article-title":"A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea","volume":"49","author":"Lee","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2016.04.011_bb0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized non-bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ejim.2016.04.011_bb0225","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/apt.13069","article-title":"Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study","volume":"41","author":"Molina-Infante","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"15","key":"10.1016\/j.ejim.2016.04.011_bb0230","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1517\/14656566.2015.1084503","article-title":"H. pylori eradication. Optimization strategies in a high resistance area","volume":"16","author":"Georgopoulos","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2016.04.011_bb0235","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2169\/internalmedicine.54.3442","article-title":"Meta-analysis of sequential, concomitant and hybrid therapy for Helicobacter pylori eradication","volume":"54","author":"He","year":"2015","journal-title":"Intern Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2016.04.011_bb0240","article-title":"High incidence of Helicobacter pylori clarithromycin resistance in Greece. A three-year multicenter laboratory surveillance study","volume":"20","author":"Martinez-Gonzales","year":"2015","journal-title":"Helicobacter"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516300802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516300802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T19:55:49Z","timestamp":1589658949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516300802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":48,"alternative-id":["S0953620516300802"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.04.011","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}